Related Experiment Video
Updated: May 11, 2026

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Antioxidant treatment strategies for hyperphenylalaninemia
Priscila Nicolao Mazzola1, George Albert Karikas, Kleopatra H Schulpis
1Programa de Pós-Graduação em Ciências Biológicas: Bioquímica. Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600 - Anexo, CEP 90035-003, Porto Alegre, RS, Brazil, pku@priscilamazzola.com.
Insights
Phenylketonuria (PKU) causes oxidative stress, impacting brain function. While diet is crucial, adherence is challenging; exploring antioxidant supplementation and exercise may offer new therapeutic avenues for PKU patients.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Hyperphenylalaninemia (HPA) in phenylketonuria (PKU) increases oxidative stress, particularly affecting the brain.
- Dietary compliance challenges in treated PKU patients lead to fluctuating phenylalanine levels and persistent oxidative stress.
- The PKU diet limits intake of natural compounds that combat reactive species and support antioxidant enzymes.
Purpose of the Study:
- To review the impact of oxidative stress in PKU and explore potential therapeutic strategies.
- To evaluate the role of nutrient supplementation and exercise in managing oxidative stress in PKU.
- To highlight the need for improved understanding and targeted treatments for PKU.
Main Methods:
- Literature review on oxidative stress in PKU.
- Analysis of existing studies on dietary interventions, nutrient supplementation, and exercise.
- Discussion of molecular biochemistry and genetics in PKU.
Main Results:
- Oxidative stress is a significant factor in PKU-related cognitive impairment.
- Supplementation with nutrients, vitamins, and tetrahydropterin shows promise.
- The role of antioxidant supplementation requires further consensus; exercise emerges as a potential adjunct therapy.
Conclusions:
- Improved understanding of PKU's molecular basis is essential for developing new treatments.
- Targeted therapeutic strategies, potentially including exercise and optimized supplementation, are needed to mitigate oxidative stress in PKU.
- Addressing dietary adherence issues and their consequences is critical for long-term PKU patient health.
Abstract:
Hyperphenylalaninemia (HPA) leads to increased oxidative stress in patients with phenylketonuria (PKU) and in animal models of PKU. Early diagnosis and immediate adherence to a phenylalanine-restricted diet prevents HPA and, consequently, severe brain damage. However, treated adolescent and adult PKU patients have difficulties complying with the diet, leading to an oscillation of phenylalanine levels and associated oxidative stress. The brain is especially susceptible to reactive species, and oxidative stress might add to the impaired cognitive function found in these patients. The restricted PKU diet has a very limited nutrient content from natural foods and almost no animal protein, which reduces the intake of important compounds. These specific compounds can act as scavengers of reactive species and can be co-factors of antioxidant enzymes. Supplementation with nutrients, vitamins, and tetrahydropterin has given quite promising results in patients and animal models. Antioxidant supplementation has been studied in HPA, however there is no consensus about its always beneficial effects. In this way, regular exercise could be a beneficial addition on antioxidant status in PKU patients. A deeper understanding of PKU molecular biochemistry, and genetics, as well as the need for improved targeted treatment options, could lead to the development of new therapeutic strategies.
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Alzheimer's Disease: Treatment
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...